Novo Nordisk Wegovy Demand Continues to Rise Faster Than Supply Can Catch Up

• (PLX AI) - Novo Nordisk said delays for prescription fills on its Wegovy obesity drug have grown to a month or longer due to strong demand in the United States.
• • Previously the delay was 3 weeks
• • Novo says delay could last through the remainder of the year
• • Aims to stabilize supply in early 2022, if not sooner